-transparent.png){kind=logo}
The serum antibody titre to the nucleoprotein (NP) of the influenza virus recombinant MRC-11 was determined in virus strains A/USSA/5/80 (H3N2), A/Hong Kong/8/64 (H3N2), A/duck/Ukraine/63 (Hav7Neq2) and in a recombinant strain between A/tern/Frunse/334/78(Hav4Nav1) and A/PR/8/34(H0N1) using the enzyme-linked immunosorbent assay (ELISA). Significant differences between the NP of these strains were found proving the usefulness for ELISA for such investigations.
Related Publications
V T Ivanova, and
H Hermann, and
Zakstelskaya LYa, and
L Döhner, and
Podchernyaeva RYa, and
V K Blinova
June 2003,
Epidemiology and infection,
V T Ivanova, and
H Hermann, and
Zakstelskaya LYa, and
L Döhner, and
Podchernyaeva RYa, and
V K Blinova
March 1986,
American journal of veterinary research,
V T Ivanova, and
H Hermann, and
Zakstelskaya LYa, and
L Döhner, and
Podchernyaeva RYa, and
V K Blinova
May 1984,
American journal of veterinary research,
V T Ivanova, and
H Hermann, and
Zakstelskaya LYa, and
L Döhner, and
Podchernyaeva RYa, and
V K Blinova
May 2014,
Journal of clinical microbiology,
V T Ivanova, and
H Hermann, and
Zakstelskaya LYa, and
L Döhner, and
Podchernyaeva RYa, and
V K Blinova
July 1982,
Journal of clinical microbiology,
V T Ivanova, and
H Hermann, and
Zakstelskaya LYa, and
L Döhner, and
Podchernyaeva RYa, and
V K Blinova
August 1983,
Infection and immunity,
V T Ivanova, and
H Hermann, and
Zakstelskaya LYa, and
L Döhner, and
Podchernyaeva RYa, and
V K Blinova
January 1981,
Archives of virology,
V T Ivanova, and
H Hermann, and
Zakstelskaya LYa, and
L Döhner, and
Podchernyaeva RYa, and
V K Blinova
January 2019,
Clinical and experimental vaccine research,
V T Ivanova, and
H Hermann, and
Zakstelskaya LYa, and
L Döhner, and
Podchernyaeva RYa, and
V K Blinova
January 1982,
Journal of biological standardization,
V T Ivanova, and
H Hermann, and
Zakstelskaya LYa, and
L Döhner, and
Podchernyaeva RYa, and
V K Blinova
January 1990,
Methods in enzymology,
